4/A//SEC Filing
Schneider Eugene 4/A
Accession 0000874015-24-000197
CIK 0000874015other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 9:06 PM ET
Size
5.7 KB
Accession
0000874015-24-000197
Insider Transaction Report
Form 4/AAmended
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
Transactions
- Sale
Common Stock
2024-02-02$49.59/sh−2,106$104,437→ 47,659 total
Footnotes (2)
- [F1]The original Form 4 filed on February 2, 2024 reported 2,071 restricted stock units sold by the reporting person which has been revised by this amendment to reflect the actual amount of shares sold and beneficially owned by Mr. Schneider.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.58 to $49.60 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001838539
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 9:06 PM ET
- Size
- 5.7 KB